TWD
NVCR icon

True Wealth Design’s NovoCure NVCR Stock Holding History

True Wealth Design’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.1K Buy
1,259
+438
+53% +$7.31K ﹤0.01% 823
2026
Q2 		$12.4K Sell
821
-315
-28% -$4.77K ﹤0.01% 986
2026
Q1 		$12.4K Sell
1,136
-381
-25% -$4.76K ﹤0.01% 904
2025
Q4 		$19.6K Buy
1,517
+579
+62% +$7.43K 0.01% 614
2025
Q3 		$12.1K Buy
938
+506
+117% +$6.76K ﹤0.01% 766
2025
Q2 		$7.69K Buy
432
+55
+15% +$958 ﹤0.01% 669
2025
Q1 		$6.72K Buy
377
+262
+228% +$5.95K ﹤0.01% 589
2024
Q4 		$3.43K Buy
+115
New +$2.43K ﹤0.01% 613
2023
Q3 		– Sell
-1
Closed -$42 – 802
2023
Q2 		$42 Hold
1
– – ﹤0.01% 766
2023
Q1 		$61 Hold
1
– – ﹤0.01% 827
2022
Q4 		$73 Buy
+1
New +$75 ﹤0.01% 757

Other funds holding NVCR

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

True Wealth Design's NVCR Position: Q3 2026 in Review

True Wealth Design increased its NovoCure (NVCR) stake by 53% in Q3 2026, buying an estimated $7.31K and bringing the position to 1,259 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #823.

True Wealth Design first reported a position in NVCR in Q4 2022 and has held it in 11 quarters since. 15 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

  • True Wealth Design held 1,259 shares of NovoCure worth $20.1K as of Q3 2026.
  • True Wealth Design bought 438 NovoCure shares in Q3 2026, an estimated $7.31K.
  • NovoCure made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #823 holding.
  • True Wealth Design first reported a position in NovoCure in Q4 2022 and has held it in 11 quarters since.
  • 15 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.